Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. (Q54590406)

1 June 2018

title

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. (English)

1 reference

1 June 2018

0 references

1 reference

Jia-Xing Zhang

1

1 reference

1 June 2018

Wu Song

2

1 reference

1 June 2018

Zhen-Hua Chen

3

1 reference

1 June 2018

Jin-Huan Wei

4

1 reference

1 June 2018

Yi-Ji Liao

5

1 reference

1 June 2018

Jian Lei

6

1 reference

1 June 2018

Ming Hu

7

1 reference

1 June 2018

Geng-Zhen Chen

8

1 reference

1 June 2018

Bing Liao

9

1 reference

1 June 2018

Jian Lu

10

1 reference

1 June 2018

Hong-Wei Zhao

11

1 reference

1 June 2018

Wei Chen

12

1 reference

1 June 2018

Yu-Long He

13

1 reference

1 June 2018

Hui-Yun Wang

14

1 reference

1 June 2018

Dan Xie

15

1 reference

1 June 2018

Jun-Hang Luo

16

1 reference

1 June 2018

publication date

13 November 2013

1 reference

1 June 2018

Lancet Oncology Commission

published in

1 reference

1 June 2018

volume

14

1 reference

1 June 2018

page(s)

1295-1306

1 reference

1 June 2018

issue

13

1 reference

1 June 2018

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Molecular markers to individualize adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

MicroRNA in colorectal cancer: from benchtop to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Diagnostic and prognostic microRNAs in stage II colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

MicroRNAs are novel biomarkers of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Direct and sensitive miRNA profiling from low-input total RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Time-dependent ROC curves for censored survival data and a diagnostic marker

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

MicroRNA sequence and expression analysis in breast tumors by deep sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

Colorectal cancer migration and invasion initiated by microRNA-106a

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970491-1

7 January 2021

10.1016/S1470-2045(13)70491-1

Identifiers

DOI

1 reference

1 June 2018

release_fqbubl2ecjfnbjsq4x2j4dlmye

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fqbubl2ecjfnbjsq4x2j4dlmye

24 November 2022

mapped directly with Wikidata item

PubMed ID

24239208

1 reference

1 June 2018